Ginkgo Bioworks Holdings, Inc.
DNA
$7.71
-$0.14-1.78%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -304.39M | -312.76M | -339.55M | -315.19M | -472.08M |
| Total Depreciation and Amortization | 38.22M | 40.25M | 42.24M | 45.94M | 46.17M |
| Total Amortization of Deferred Charges | 18.20M | 18.20M | 18.20M | 17.50M | 18.80M |
| Total Other Non-Cash Items | 128.45M | 122.63M | 126.90M | 139.47M | 222.09M |
| Change in Net Operating Assets | -46.70M | -39.37M | -13.61M | -125.43M | -96.83M |
| Cash from Operations | -166.22M | -171.06M | -165.82M | -237.71M | -281.85M |
| Capital Expenditure | -1.98M | -7.67M | -21.37M | -36.46M | -63.45M |
| Sale of Property, Plant, and Equipment | 574.00K | 574.00K | 57.00K | 648.00K | 648.00K |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.07M | -233.20M | -327.16M | -250.05M | -186.01M |
| Cash from Investing | -18.47M | -240.29M | -348.47M | -285.86M | -248.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -166.00K | -354.00K | -532.00K | -708.00K | -810.00K |
| Issuance of Common Stock | 19.47M | 19.47M | 10.32M | 0.00 | 14.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.34M | -1.34M | -355.00K | -265.00K | -305.00K |
| Cash from Financing | 17.96M | 17.78M | 9.43M | -973.00K | -1.10M |
| Foreign Exchange rate Adjustments | -2.00K | 201.00K | 280.00K | 152.00K | -50.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -166.74M | -393.37M | -504.58M | -524.39M | -531.81M |